In all-comer cohort of immunocompetent individuals at risk of contracting symptomatic COVID-19 in their everyday social interactions, participants receiving pemivibart experienced a 1.9% rate of ...

Researchers provided comprehensive evidence of the benefits of statin use in elderly patients, addressing longstanding uncertainties. The robust evidence demonstrated that continuous statin therapy ...

Statins Relative Risk Reduction: Statin medications are prescribed to reduce the risk of heart disease and heart attack. However, their benefits vary from person to person. Let us explain them.

The blockbuster diabetes and weight loss drug semaglutide (Wegovy, Ozempic, Rybelsus) reduced the relative risk of heart attack, stroke, or cardiovascular deaths by 20 percent in high-risk patients ...

Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.

NEW ORLEANS — The first global randomized trial of the PCSK9 inhibitor evolocumab for the prevention of a primary major adverse cardiovascular event (MACE) found a relative reduction in risk similar ...

CKD patients face higher CVD risk, with dyslipidemia differing from the general population, necessitating tailored lipid ...

Learn how the Kenney Rule helps insurers manage risk by maintaining a balanced ratio of unearned premiums to policyholders' surplus, ensuring financial stability.